Cyted uses artificial intelligence (AI) and digital pathology to improve the detection and diagnosis of diseases, including cancer.
Cyted has raised $44.0M in total funding. The most recent round was Series B. The last funding was announced in August 2025.
Cyted's investors include British Business Bank, EQT Life Sciences, Innovate UK, Morningside, NHS England.
Cyted is headquartered in Cambridge, United Kingdom.
Cyted uses artificial intelligence (AI) and digital pathology to improve the detection and diagnosis of diseases, including cancer.
Cyted is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cyted — Funding & Investors." VCBacked, August 30, 2025, https://www.vcbacked.co/company/cyted. Accessed August 13, 2026.
VCBacked. (2025). Cyted — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/cyted
{{cite web |title=Cyted — Funding & Investors |url=https://www.vcbacked.co/company/cyted |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated